Artiva Biotherapeutics, Inc. (NASDAQ:ARTV) filed a Form 8-K with the Securities and Exchange Commission on February 24, 2026, disclosing a material event. Artiva Biotherapeutics,…
Artiva Biotherapeutics, Inc. (NASDAQ:ARTV) filed a Form 8-K with the Securities and Exchange Commission on February 24, 2026, disclosing a material event.
Artiva Biotherapeutics, Inc.'s stock currently trades at $5.02 with a market capitalization of $77.1M. The Healthcare company's stock moved following the disclosure.
Current market data
NASDAQ · ARTV
$11.94
Down: -$0.39 · -3.22%
Live quote updated
Keep reading
earnings ·
sec_filing ·
earnings ·
sec_filing ·
